… whether the plasma proteome adds value to established predictors in heart failure (HF) with
reduced ejection fraction (HFrEF). We sought to derive and validate a plasma proteomic risk …

… The results in this study showed that plasma proteomics provides insights into the
pathogenesis of disease progression in HF that would open new perspectives for translational …

… heart failure (HF) with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF)…
We aimed to identify specific proteomic patterns for HF, by comparing proteomic profiles …

… The intracellular transcription factors TP53, HNF1B, HIF1A/ARNT, and STAT6, which are
not measured in our plasma protein panels, may complement the biomarker profile of patients …

… proteomic profiling platform. In total, 203 proteins were significantly modulated in the plasma
… 1, we then used 2 strategies for analysing our high-throughput proteomic profiles. First, we …

… Of those, we have proteomic data in 761 individuals. A total of 166 subjects were
excluded from the analyses due to prevalent CVD at the baseline examination at age 77. …

… with dilated cardiomyopathy combined with heart failure (DCM-HF), providing comprehensive
proteomic insights. … Landscape of plasma proteins profile. (A) Heatmap of all expressed …

… We hypothesized that plasma proteomic analysis can identify … -free quantitative proteomics
approach was used in plasma … In conclusion, plasma proteomic profile provides biomarkers …

… Proteomics has been used to provide prognostic information in various diseases. Our aim
… value of plasma proteomic profiling for risk stratification in HF. A proteomic profiling using …

… Patients with rheumatoid arthritis and heart failure largely share similar mechanistic
pathways with patients with heart failure without rheumatoid arthritis. These include a higher …